WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009137251) CYSTEINE AND CYSTINE BIOISOSTERES TO TREAT SCHIZOPHRENIA AND REDUCE DRUG CRAVINGS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/137251    International Application No.:    PCT/US2009/040799
Publication Date: 12.11.2009 International Filing Date: 16.04.2009
IPC:
C07D 271/06 (2006.01), C07D 413/12 (2006.01), A61P 25/18 (2006.01), A61P 25/30 (2006.01), A61K 31/4245 (2006.01), C07C 323/02 (2006.01)
Applicants: MARQUETTE UNIVERSITY [US/US]; 1324 West Wisconsin Avenue, Suite 341 Milwaukee, WI 53233 (US) (For All Designated States Except US).
UNIVERSITY OF WISCONSIN-MILWAUKEE RESEARCH FOUNDATION [US/US]; P.O. Box 170581 Milwaukee, WI 53217-0851 (US) (For All Designated States Except US).
COOK, James, M. [US/US]; (US) (For US Only).
BAKER, David, A. [US/US]; (US) (For US Only).
YIN, Wenyuan [CN/US]; (US) (For US Only).
JOHNSON, Edward, Merle [US/US]; (US) (For US Only)
Inventors: COOK, James, M.; (US).
BAKER, David, A.; (US).
YIN, Wenyuan; (US).
JOHNSON, Edward, Merle; (US)
Agent: LEECK, Charles, L.; (US)
Priority Data:
61/045,386 16.04.2008 US
Title (EN) CYSTEINE AND CYSTINE BIOISOSTERES TO TREAT SCHIZOPHRENIA AND REDUCE DRUG CRAVINGS
(FR) BIOISOSTÈRES DE LA CYSTÉINE ET DE LA CYSTINE DESTINÉS À TRAITER LA SCHIZOPHRÉNIE ET À SOULAGER LES ÉTATS DE MANQUE
Abstract: front page image
(EN)The present invention provides cysteine and cystine bioisosteres for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing such bioisosteres and methods of using the bioisosteres for treatment of schizophrenia and drug addiction.
(FR)L'invention concerne des bioisostères de la cystéine et de la cystine destinés au traitement de la schizophrénie et de la pharmacodépendance. L'invention porte en outre sur des compositions pharmaceutiques contenant lesdits bioisostères et sur des procédés d'utilisation des bioisostères dans le traitement de la schizophrénie et de la pharmacodépendance.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)